Bracket, a division of UBC, has joined the Electronic Patient-Reported Outcome (ePRO) Consortium, which seeks to improve the quality of patient reported outcomes, a crucial element in the drug development process.
The ePRO Consortium, a program run by the Critical Path Institute (C-Path), is committed to advancing the quality, practicality and acceptance of electronic data capture (EDC) methods used in clinical trials for PRO endpoint assessment. PROs provide the patients’ perspectives of a medication or device during clinical trials and other clinical research studies, with endpoints including quality of life, symptoms, functioning, cognition and general health status.
Bracket will work with other members of the ePRO Consortium in a non-competitive, neutral environment to develop guidelines and advance the quality of electronic data collection methods for PROs. The consortium, which was formed in 2011, will collaborate with C-Path’s PRO Consortium, a group of pharmaceutical companies working to improve PRO measurement for high-priority therapeutic areas to help migrate new PRO measures to the appropriate electronic data capture format. The ePRO Consortium will also develop guidance on methodological considerations for PRO instrument migration and adaptation.
“Incorporating the patient perspective in innovation and using new technology, like ePRO, in a scalable manner is crucial to expanding and enhancing all aspects of electronic patient reported outcomes,” said Dr. Robert Epstein, UBC president. “Partnering with the Critical Path Institute creates yet another venue for us to continue to advocate and innovate for the development of safe and effective drugs for patients.”
